Effect of ınhaler Use on Oral Health in COPD Patients
Recruiting · NCT07000604 · Interventional (participants receive a specific treatment) · Lead sponsor: Çankırı Karatekin University
View the official record on ClinicalTrials.gov →Interventions studied
Mouth Care Training
What this trial is about
The aim of this study was to evaluate the effect of oral health education given to individuals diagnosed with COPD and using inhaled medication.
Who can take part
Age range
35 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosed with COPD for at least 6 months,
- Outpatient and inpatient,
- Consent to participate in the research,
- Not under the age of eighteen,
- With a metered dose inhaler (MDI) in treatment,
- No communication barriers,
- No COPD exacerbation and/or respiratory tract infection,
- According to the GOLD report; mild (Stage 1), moderate (Stage 2), severe (Stage 3).
Exclusion criteria
- Diagnosed with COPD for less than 6 months,
- Refused to participate in the research,
- Treatment without metered dose inhalers (MDIs),
- Uncommunicative,
- Those who withdrew from participating in the study during data collection,
- Not completing the survey,
- COPD exacerbation and/or respiratory tract infection,
Where it is running
1 location listed.
- Çankiri Devlet Hastanesi - Çankırı, Turkey (Türkiye)